Phibro Animal Health Corporation

NasdaqGM:PAHC Voorraadrapport

Marktkapitalisatie: US$863.1m

De vertaling van deze pagina is experimenteel en in ontwikkeling. Uw is welkom!

Phibro Animal Health Beheer

Beheer criteriumcontroles 2/4

De CEO Phibro Animal Health's is Jack Bendheim, benoemd in Jan1988, heeft een ambtstermijn van 36.75 jaar. De totale jaarlijkse vergoeding van { bedraagt $ 4.75M, bestaande uit 49.6% salaris en 50.4% bonussen, inclusief aandelen en opties van het bedrijf. bezit rechtstreeks 49.94% van de aandelen van het bedrijf, ter waarde $ 455.48M. De gemiddelde ambtstermijn van het managementteam en de raad van bestuur bedraagt respectievelijk 7 jaar en 15.3 jaar.

Belangrijke informatie

Jack Bendheim

Algemeen directeur

US$4.8m

Totale compensatie

Percentage CEO-salaris49.6%
Dienstverband CEO36.8yrs
Eigendom CEO49.9%
Management gemiddelde ambtstermijn7yrs
Gemiddelde ambtstermijn bestuur15.3yrs

Recente managementupdates

Recent updates

Phibro Animal Health Corporation's (NASDAQ:PAHC) Shares Bounce 26% But Its Business Still Trails The Industry

Sep 14
Phibro Animal Health Corporation's (NASDAQ:PAHC) Shares Bounce 26% But Its Business Still Trails The Industry

Phibro Animal Health (NASDAQ:PAHC) Has Affirmed Its Dividend Of $0.12

Aug 29
Phibro Animal Health (NASDAQ:PAHC) Has Affirmed Its Dividend Of $0.12

Phibro Animal Health (NASDAQ:PAHC) Will Pay A Dividend Of $0.12

Aug 15
Phibro Animal Health (NASDAQ:PAHC) Will Pay A Dividend Of $0.12

New Forecasts: Here's What Analysts Think The Future Holds For Phibro Animal Health Corporation (NASDAQ:PAHC)

May 14
New Forecasts: Here's What Analysts Think The Future Holds For Phibro Animal Health Corporation (NASDAQ:PAHC)

Phibro Animal Health (NASDAQ:PAHC) Is Paying Out A Dividend Of $0.12

May 11
Phibro Animal Health (NASDAQ:PAHC) Is Paying Out A Dividend Of $0.12

Phibro Animal Health: An Interesting Deal With Zoetis For A Struggling Business

May 01

Market Participants Recognise Phibro Animal Health Corporation's (NASDAQ:PAHC) Earnings Pushing Shares 30% Higher

Apr 30
Market Participants Recognise Phibro Animal Health Corporation's (NASDAQ:PAHC) Earnings Pushing Shares 30% Higher

Phibro Animal Health (NASDAQ:PAHC) Is Due To Pay A Dividend Of $0.12

Feb 10
Phibro Animal Health (NASDAQ:PAHC) Is Due To Pay A Dividend Of $0.12

Phibro Animal Health (NASDAQ:PAHC) Use Of Debt Could Be Considered Risky

Dec 06
Phibro Animal Health (NASDAQ:PAHC) Use Of Debt Could Be Considered Risky

Phibro Animal Health's (NASDAQ:PAHC) Dividend Will Be $0.12

Nov 10
Phibro Animal Health's (NASDAQ:PAHC) Dividend Will Be $0.12

A Look At The Fair Value Of Phibro Animal Health Corporation (NASDAQ:PAHC)

Nov 05
A Look At The Fair Value Of Phibro Animal Health Corporation (NASDAQ:PAHC)

Phibro Animal Health (NASDAQ:PAHC) Has Affirmed Its Dividend Of $0.12

Aug 28
Phibro Animal Health (NASDAQ:PAHC) Has Affirmed Its Dividend Of $0.12

Phibro Animal Health (NASDAQ:PAHC) Is Paying Out A Dividend Of $0.12

Jul 29
Phibro Animal Health (NASDAQ:PAHC) Is Paying Out A Dividend Of $0.12

Phibro Animal Health (NASDAQ:PAHC) Is Due To Pay A Dividend Of $0.12

Feb 10
Phibro Animal Health (NASDAQ:PAHC) Is Due To Pay A Dividend Of $0.12

Is Phibro Animal Health Corporation (NASDAQ:PAHC) Worth US$13.8 Based On Its Intrinsic Value?

Dec 23
Is Phibro Animal Health Corporation (NASDAQ:PAHC) Worth US$13.8 Based On Its Intrinsic Value?

Phibro Animal Health's (NASDAQ:PAHC) Dividend Will Be $0.12

Aug 26
Phibro Animal Health's (NASDAQ:PAHC) Dividend Will Be $0.12

Phibro Animal Non-GAAP EPS of $0.36 misses by $0.02, revenue of $255.3M beats by $5.26M

Aug 24

Is Phibro Animal Health (NASDAQ:PAHC) A Risky Investment?

Aug 24
Is Phibro Animal Health (NASDAQ:PAHC) A Risky Investment?

Phibro Animal Health (NASDAQ:PAHC) Has Affirmed Its Dividend Of $0.12

Jul 29
Phibro Animal Health (NASDAQ:PAHC) Has Affirmed Its Dividend Of $0.12

Phibro Animal declares $0.12 dividend

Jul 25

Phibro Animal Health's (NASDAQ:PAHC) Dividend Will Be US$0.12

May 06
Phibro Animal Health's (NASDAQ:PAHC) Dividend Will Be US$0.12

Analyse CEO-vergoeding

Hoe is Jack Bendheim's beloning veranderd ten opzichte van Phibro Animal Health's winst?
DatumTotale vergoedingSalarisBedrijfswinsten
Jun 30 2024US$5mUS$2m

US$2m

Mar 31 2024n/an/a

US$13m

Dec 31 2023n/an/a

US$15m

Sep 30 2023n/an/a

US$21m

Jun 30 2023US$3mUS$2m

US$33m

Mar 31 2023n/an/a

US$29m

Dec 31 2022n/an/a

US$36m

Sep 30 2022n/an/a

US$46m

Jun 30 2022US$4mUS$2m

US$49m

Mar 31 2022n/an/a

US$59m

Dec 31 2021n/an/a

US$53m

Sep 30 2021n/an/a

US$49m

Jun 30 2021US$4mUS$2m

US$54m

Mar 31 2021n/an/a

US$43m

Dec 31 2020n/an/a

US$44m

Sep 30 2020n/an/a

US$43m

Jun 30 2020US$3mUS$2m

US$34m

Mar 31 2020n/an/a

US$37m

Dec 31 2019n/an/a

US$38m

Sep 30 2019n/an/a

US$41m

Jun 30 2019US$3mUS$2m

US$55m

Mar 31 2019n/an/a

US$68m

Dec 31 2018n/an/a

US$73m

Sep 30 2018n/an/a

US$65m

Jun 30 2018US$3mUS$2m

US$65m

Compensatie versus markt: De totale vergoeding ($USD 4.75M ) Jack } ligt boven het gemiddelde voor bedrijven van vergelijkbare omvang in de US markt ($USD 3.23M ).

Compensatie versus inkomsten: De beloning van Jack is het afgelopen jaar met meer dan 20% gestegen, terwijl de winst van het bedrijf met meer dan 20% is gedaald.

CEO

Jack Bendheim (77 yo)

36.8yrs

Tenure

US$4,753,878

Compensatie

Mr. Jack Clifford Bendheim has been the President and Chief Executive Officer of Phibro Animal Health Corporation since 1988 and March 2014, respectively and serves as its Chairman. Mr. Bendheim served as...

Leiderschapsteam

NaamPositieTenureCompensatieEigendom
Jack Bendheim
Chairman36.8yrsUS$4.75m49.94%
$ 431.0m
Glenn David
Chief Financial Officerless than a yearUS$2.40mgeen gegevens
Larry Miller
Chief Operating Officer8.3yrsUS$3.42m0.074%
$ 639.3k
Daniel Bendheim
Executive VP of Corporate Strategy & Director10.6yrsUS$763.24kgeen gegevens
Rob Aukerman
President of North America Region5.4yrsUS$752.70kgeen gegevens
Judith Weinstein
Senior VP1.3yrsgeen gegevensgeen gegevens
Lisa Escudero
Senior Vice President of Human Resources7.6yrsgeen gegevensgeen gegevens
Jonathan Bendheim
President of MACIE Regionno datageen gegevensgeen gegevens
Ramon Fuenmayor
President South America Region7.3yrsgeen gegevensgeen gegevens
Samson Li
President of Asia Pacific Region1.5yrsgeen gegevensgeen gegevens
Michael Giambalvo
President of PhibroChem and Ethanol Performance Groupno datageen gegevensgeen gegevens
Anthony Andolino
VP of Finance & Treasurer6.6yrsgeen gegevensgeen gegevens

7.0yrs

Gemiddelde duur

55yo

Gemiddelde leeftijd

Ervaren management: Het managementteam van PAHC is doorgewinterd en ervaren (gemiddelde ambtstermijn van 7 jaar).

Bestuursleden

NaamPositieTenureCompensatieEigendom
Jack Bendheim
Chairman40.8yrsUS$4.75m49.94%
$ 431.0m
Daniel Bendheim
Executive VP of Corporate Strategy & Director10.9yrsUS$763.24kgeen gegevens
Jonathan Bendheim
President of MACIE Region6.2yrsgeen gegevensgeen gegevens
Samuel Gejdenson
Independent Non-Executive Director20.8yrsUS$60.00kgeen gegevens
Mary Malanoski
Independent Non Executive Director20.4yrsUS$40.00kgeen gegevens
Carol Wrenn
Independent Director14.3yrsUS$60.00k0.0025%
$ 21.3k
E. Corcoran
Independent Non-Executive Director16.4yrsUS$50.00k0.062%
$ 532.7k
Alejandro Bernal
Independent Director1.7yrsUS$50.00kgeen gegevens

15.3yrs

Gemiddelde duur

65yo

Gemiddelde leeftijd

Ervaren bestuur: De raad van bestuur van PAHC zijn ervaren en ervaren (gemiddelde ambtstermijn van 15.3 jaar).